Investing

Top Analyst Upgrades and Downgrades: AbbVie, Biogen, Cree, Etsy, Gilead, Pfizer, Rite Aid, Solar Edge, Square, 3D Systems, Virgin Galactic and More

General Dynamics Corp. (NYSE: GD) was raised to Positive from Neutral with a $210 target price (versus a $171.55 close) at Susquehanna.

Gilead Sciences Inc. (NASDAQ: GILD) was started with an Underweight rating and a $62 target price at Barclays. The stock closed up over 6% at $74.70, after starting trials here in the United States to see if its drug can help cure the coronavirus. Shares were indicated up another 5.1% at $78.52 on Thursday.

Logitech International S.A. (NASDAQ: LOGI) was raised to Overweight from Neutral with a $48 target price at JPMorgan. Shares closed up 0.2% at $39.23, and the consensus target price was $54.20.

Medifast Inc. (NYSE: MED) was last seen down 15% at $80.20, despite beating earnings expectations. Jefferies downgraded it to Hold from Buy.

Pfizer Inc. (NYSE: PFE) was started with an Equal Weight rating and a $36 target price (versus a $34.72 close) at Barclays. Pfizer had a consensus target price of $42.54.

Rite Aid Corp. (NYSE: RAD) was raised to Neutral from Sell at Guggenheim. The stock traded down 3.4% at $13.03, and its shares were indicated down at $12.80 on Thursday.

Sabre Corp. (NASDAQ: SABR) was down 16% at $16.15 on Wednesday after the travel software and technology provider warned of widespread cancellations and lower bookings due to the coronavirus. Oppenheimer downgraded it to Perform from Outperform. Its prior consensus target price was $23.50.

SolarEdge Technologies Inc. (NASDAQ: SEDG) was named as the Bull of the Day again at Zacks, which said that the stock has soared over the past year and the company topped earnings in the fourth quarter. Shares most recently closed at $132.41, with a consensus price target of $124.83.

Square Inc. (NYSE: SQ) was down 0.6% at $76.59 ahead of earnings but was last seen trading up 4% at $79.65 afterward. Canaccord Genuity raised its Hold rating to Buy. SunTrust Robinson Humphrey reiterated its Buy rating and raised its target to $100. Needham reiterated its Buy rating and raised its target price to $105 from $80, and JPMorgan reiterated its Overweight rating and raised its target to $86 from $75.

StoneCo. Ltd. (NASDAQ: STNE) was raised to Overweight from Neutral and its target price was raised to $48 from $43 (versus a $41.57 close) at JPMorgan. The 52-week range is $23.15 to $45.72.

3D Systems Corp. (NYSE: DDD) was maintained as Neutral but its target price was raised to $10 from $8 (versus a $10.24 close) at B. Riley FBR.

Toll Brothers Inc. (NYSE: TOL) was raised to Outperform from Neutral with a $48 target price (versus a $37.82 close) at Wedbush. That is after a 14.6% drop on Wednesday, and shares were indicated down another 2% at $37.10 on Thursday morning.

United Therapeutics Corp. (NASDAQ: UTHR) was raised to Outperform from Market Perform with a $145 target price (versus a $105.81 close) at Cowen.

Virgin Galactic Holdings Inc. (NYSE: SPCE) was downgraded to Neutral from Outperform with a $25 target price at Credit Suisse, and Morgan Stanley downgraded it to Equal Weight from Overweight with a $30 target price. The stock closed down 15.5% at $28.75, and its recent high was $42.49. Shares were indicated down 14% at $24.60 on Thursday morning.

With the coronavirus now on our shores, it makes sense to look at stocks that consumers need regardless of temporary or, perhaps even worse, long-term health issues.

Wednesday’s top analyst upgrades and downgrades included Casper Sleep, CME, Deere, Domino’s Pizza, Home Depot, Nike, RealReal, Salesforce.com, SolarEdge Technologies, Sunrun, Walt Disney and many more.